Archives: Resources

An ongoing anemia study with thousands of patients enrolled at hundreds of sites around the world was at risk of delays due to the COVID-19 pandemic. With a complex protocol that included cold chain comparator and controlled ambient investigational medicinal product (IMP), there was a need to rapidly adapt and provide a solution so dosing patients could continue and that travel to clinical sites would not be a requirement during this time.

An all-in-one capacity management solution designed to expand access to services and talent, protect budgets and set you up for success.

Our digital trial team leveraged key digital and operational capabilities to rescue and decentralize a study in a matter of days. As a result, patient assessments were able to continue as planned through TeleVisits. The strategy also ensured patient safety and primary endpoint collection was maintained.

PPD and our partner NeoGenomics provide comprehensive clinical trial and drug development service offerings in the oncology continuum.